Corbus Pharmaceuticals Holdings, Inc.
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs apply
About CRBP
Corbus Pharmaceuticals Holdings, Inc. is an oncology and obesity company. The Company has a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The Company’s oncology pipeline comprises two experimental drugs targeting solid tumors: CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, and CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFB expressed on cancer cells. CRB-701 is a monoclonal antibody attached to a monomethyl auristatin E (MMAE) cytotoxic payload using a proprietary linker technology. The pipeline also includes CRB-913, a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. CB1 inverse agonism is a clinically validated mechanism to induce weight loss.
Find out what a historical investment in Corbus Pharmaceuticals Holdings, Inc. would be worth today using our CRBP stock calculator.
$78.93M
-
0.00%
126.38K
$6.91
$6.33
$6.65
$61.90
$4.64
Ready to start your investing journey with Stake?
Open an accountCRBP FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in CRBP
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in CRBP
on Stake
Buy CRBP from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of CRBP from only US$10 with fractional shares
